+13.1%
GSK vs IRM
+19.5%
-6.3%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | IRM | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.0% | +1.7% | +3.3% | +5.0% |
| 7D | +4.9% | +2.6% | +2.4% | +4.9% |
| 30D | +9.9% | +5.6% | +4.2% | +9.7% |
| 3M | +0.2% | -4.7% | +4.9% | +0.2% |
| 6M | +2.3% | -6.1% | +8.4% | +2.5% |
| YTD | +7.1% | +46.3% | -39.3% | +2.0% |
| 1Y | +13.1% | +18.7% | -5.6% | +11.5% |
| All | +13.1% | +19.5% | -6.3% | +11.5% |
Cumulative growth
Daily Returns
Daily percentage return beside IRM.
Daily Out/Under-Performance
Portfolio return minus IRM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × IRM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded IRM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling